Offered without comment except to discuss with your Physician If they are aware and of their opinion. Note date of report
Commencement of Zytiga therapy and co... - Advanced Prostate...
Commencement of Zytiga therapy and corresponding rise in cardiovascular events.


This a cohort study of 87 patients treated with abiraterone and prednisone. They did not find major cardiovascular problems except for worsening of previous hypertension.
The median patient age was 75 years. 2/3 of these men had at least 1 pre-existing CVD.
Given the dates of the study, and the 15.8% crude 6-month post-abiraterone mortality rate, I infer that most or all of these men had quite advanced mCRPC, and that many of those deaths were due to the cancer.
I can't get to the full article, but the snippet doesn't appear to make any claim that these results are statistically significant. It appears to be a pitch for funding a new study.
The article gave me Heart Burn.....
Good Luck, Good Health and Good Humor.
j-o-h-n Thursday 04/25/2019 4:55 PM DST